Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
KNSA Kiniksa Pharmaceuticals International
- 20.590
- +0.100+0.49%
Close Dec 20 16:00 ET
- 20.590
- 0.0000.00%
Post 16:11 ET
1.49BMarket Cap-171.58P/E (TTM)
20.690High20.200Low592.65KVolume20.330Open20.490Pre Close12.18MTurnover3.51%Turnover Ratio102.95P/E (Static)72.20MShares28.15052wk High3.40P/B347.27MFloat Cap16.56052wk Low--Dividend TTM16.87MShs Float32.880Historical High--Div YieldTTM2.39%Amplitude5.010Historical Low20.547Avg Price1Lot Size
About Kiniksa Pharmaceuticals International Company
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
Company Profile
SymbolKNSA
Company NameKiniksa Pharmaceuticals International
Listing DateMay 24, 2018
Issue Price18.00
Founded2024
CEOMr. Sanj K. Patel
MarketNASDAQ
Employees297
Fiscal Year Ends12-31
Address23 Old Bond Street,3rd Floor
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW1S 4PZ
Phone44-781-431-9100
Websitehttps://www.kiniksa.com
Company Executives
- Name
- Position
- Salary
- Sanj K. Patel
- Chief Executive Officer and Chairman of the Board
- 5.30M
- Mark Ragosa
- Senior Vice President and Chief Financial Officer
- --
- Eben Tessari
- Senior Vice President and Chief Operating Officer
- 1.75M
- John F. Paolini, M.D.,PhD
- Senior Vice President and Chief Medical Officer
- 1.79M
- Ross Moat
- Senior Vice President and Chief Commercial Officer
- --
- Michael R. Megna
- Chief Accounting Officer and Group Vice President, Finance
- --
- Cantey Boyd
- Director
- --
- Dr. Stephen R. Biggar,M.D.,PhD
- Independent Director
- 371.96K
- Tracey L. McCain, Esq.
- Independent Director
- 365.36K
- G. Bradley Cole
- Independent Director
- 365.36K
- Thomas R. Malley
- Independent Director
- 380.36K
- Kimberly J. Popovits
- Independent Director
- 362.66K
- Dr. Richard S. Levy,M.D.
- Independent Director
- 459.75K
- Dr. Felix J. Baker,PhD
- Lead Independent Director
- 411.06K
- Dr. Barry D. Quart,Pharm.D.
- Independent Director
- 372.55K